Typhoid fever screening: Difference between revisions
Jump to navigation
Jump to search
(Category) |
Aysha Aslam (talk | contribs) No edit summary |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Typhoid fever}} | {{Typhoid fever}} | ||
{{CMG}}; {{AE}}{{ | {{CMG}}; {{AE}}{{AAA}} | ||
==Overview== | ==Overview== | ||
Line 20: | Line 20: | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:FinalQCRequired]] | [[Category:FinalQCRequired]] | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
Latest revision as of 02:40, 18 July 2021
Typhoid fever Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Typhoid fever screening On the Web |
American Roentgen Ray Society Images of Typhoid fever screening |
Risk calculators and risk factors for Typhoid fever screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aysha Aslam, M.B.B.S[2]
Overview
There are no screening guidelines for typhoid fever. However, chronic carriers can be screened using ELISA to detect antibodies against the Vi antigen.[1][2]
Screening
There are no screening guidelines for typhoid fever. However, chronic carriers can be screened using ELISA to detect antibodies against the Vi antigen.[2]
References
- ↑ http://www.uspreventiveservicestaskforce.org/
- ↑ 2.0 2.1 Lanata CF, Levine MM, Ristori C, Black RE, Jimenez L, Salcedo M; et al. (1983). "Vi serology in detection of chronic Salmonella typhi carriers in an endemic area". Lancet. 2 (8347): 441–3. PMID 6192305.